|
1
|
Feher M and Schmidt JM: Property
distributions: Differences between drugs, natural products, and
molecules from combinatorial chemistry. J Chem Inf Comput Sci.
43:218–227. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Li J, Larregieu CA and Benet LZ:
Classification of natural products as sources of drugs according to
the biopharmaceutics drug disposition classification system
(BDDCS). Chin J Nat Med. 14:888–897. 2016.PubMed/NCBI
|
|
3
|
Gerwick WH: Plant sources of drugs and
chemicalsEncyclopedia of Biodiversity. 2nd. Elsevier Inc.; pp.
129–139. 2013, View Article : Google Scholar
|
|
4
|
Butler MS: The role of natural product
chemistry in drug discovery. J Nat Prod. 67:2141–2153. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Eddershaw PJ, Beresford AP and Bayliss MK:
ADME/PK as part of a rational approach to drug discovery. Drug
Discov Today. 5:409–414. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bérdy J: Thoughts and facts about
antibiotics: Where we are now and where we are heading. J.
Antibiotics (Basel). 65:385–395. 2012. View Article : Google Scholar
|
|
7
|
Gao Y, Deng K, Cao Z, Graziani EI, Gilbert
AM, Koehn FE, Wood A, Doherty P and Walsh FS: Amphotericin B,
identified from a natural product screen, antagonizes CNS
inhibitors to promote axon growth via activation of an Akt pathway
in neurons. J Neurochem. 113:1331–1342. 2010.PubMed/NCBI
|
|
8
|
Zhang L and Demain AL: Nautral Products:
Drug Discovery and Therapeutic Medicine. Humana Press Inc.; Totowa,
NJ: pp. 3–29. 2005
|
|
9
|
Mottamal M, Zheng S, Huang TL and Wang G:
Histone deacetylase inhibitors in clinical studies as templates for
new anticancer agents. Molecules. 20:3898–3941. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Patwardhan B, Vaidya ADB and Chorghade M:
Ayurveda and Traditional Chinese Medicine: A Comparative Overview.
Curr Sci Assoc/Indian Academy of Sciences. 86:789–799. 2004.
|
|
11
|
Cragg GM and Newman DJ: Natural products:
A continuing source of novel drug leads. Biochim Biophys Acta.
1830:3670–3695. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Oshiro BT: The semisynthetic penicillans.
Prim Care Update Ob Gyns. 6:56–60. 1999. View Article : Google Scholar
|
|
13
|
Lahlou M: The Success of Natural Products
in Drug Discovery. Pharmacol Pharm. 4:17–31. 2013. View Article : Google Scholar
|
|
14
|
Chin YW, Balunas MJ, Chai HB and Kinghom
AD: Drug Discovery from Natural Sources. AAPS J. 8:239–242. 2006.
View Article : Google Scholar
|
|
15
|
Valecha N, Looareesuwan S, Martensson A,
Abdulla SM, Krudsood S, Tangpukdee N, Mohanty S, Mishra SK, Tyagi
PK, Sharma SK, et al: Arterolane, a new synthetic trioxolane for
treatment of uncomplicated Plasmodium falciparum malaria: A phase
II, multicenter, randomized, dose-finding clinical trial. Clin
Infect Dis. 51:684–691. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Pascolutti M and Quinn RJ: Nautral
producsts as lead structures: chemical transformations to create
lead-like libraries. Drug Discov Today. 19:215–221. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cordell GA: Biodiversity and drug
discovery - a symbiotic relationship. Phytochemistry. 55:463–480.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Atanasov AG, Waltenberger B,
Pferschy-Wenzig EM, Linder T, Wawrosch C, Uhrin P, Temml V, Wang L,
Schwaiger S, Heiss EH, et al: Discovery and resupply of
pharmacologically active plant-derrived natural products: A review.
Biotechnol Adv. 33:1582–1614. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ji HF, Li XJ and Zhang HY: Natural
products and drug discovery. Can thousands of years of ancient
medical knowledge lead us to new and powerful drug combinations in
the fight against cancer and dementia? EMBO Rep. 10:194–200.
2009.PubMed/NCBI
|
|
20
|
Shaban NS, Abdou KA and Hassan N E-HY:
Impact of toxic heavy metals and pesticide residues in herbal
products. Beni-Suef University Journal of Basic and Applied
Sciences. 5:102–106. 2016. View Article : Google Scholar
|
